Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
18.51
+0.02 (0.11%)
Sep 2, 2026, 4:00 PM EDT - Market closed
Relay Therapeutics Market Cap
Relay Therapeutics has a market cap or net worth of $4.06 billion as of September 2, 2026. Its market cap has increased by 555.35% in one year.
Market Cap
4.06B
Enterprise Value
3.18B
1-Year Change
555.35%
Ranking
Category
Stock Price
$18.51
ChartMarket Cap Chart
Since July 16, 2020, Relay Therapeutics's market cap has increased from $3.03B to $4.06B, an increase of 33.66%. That is a compound annual growth rate of 4.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 4.06B | 176.63% |
| Dec 31, 2025 | 1.47B | 112.63% |
| Dec 31, 2024 | 689.62M | -49.19% |
| Dec 29, 2023 | 1.36B | -24.86% |
| Dec 30, 2022 | 1.81B | -45.57% |
| Dec 31, 2021 | 3.32B | -11.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Enliven Therapeutics | 4.24B |
| Legend Biotech | 4.09B |
| Veradermics | 4.07B |
| Viking Therapeutics | 3.93B |
| IDEAYA Biosciences | 3.85B |
| Arcus Biosciences | 3.78B |
| Tango Therapeutics | 3.77B |
| Iovance Biotherapeutics | 3.75B |